Cargando…

The Prevalence of Pregnancy-Specific Perinatal Anxiety in Nova Scotia

OBJECTIVES: Pregnancy-Specific Perinatal Anxiety (PSPA) is an understudied mental health condition of pregnancy that may affect maternal-fetal health outcomes. The purpose of this study was to determine the prevalence of PSPA among pregnant women in the province of Nova Scotia, Canada, as well as th...

Descripción completa

Detalles Bibliográficos
Autores principales: Langille, Courtney, Andreou, Pantelis, Piccinini-Vallis, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067513/
https://www.ncbi.nlm.nih.gov/pubmed/37005936
http://dx.doi.org/10.1007/s10995-023-03639-y
_version_ 1785018489394692096
author Langille, Courtney
Andreou, Pantelis
Piccinini-Vallis, Helena
author_facet Langille, Courtney
Andreou, Pantelis
Piccinini-Vallis, Helena
author_sort Langille, Courtney
collection PubMed
description OBJECTIVES: Pregnancy-Specific Perinatal Anxiety (PSPA) is an understudied mental health condition of pregnancy that may affect maternal-fetal health outcomes. The purpose of this study was to determine the prevalence of PSPA among pregnant women in the province of Nova Scotia, Canada, as well as the factors associated with it. METHODS: A sample of 90 pregnant women provided data on PSPA symptomology and demographic co-variables via a self-report online survey. The prevalence of PSPA in the sample was calculated and bivariate statistics and binomial logistic regression were conducted to assess the relationship between the presence of PSPA and the independent variables. RESULTS: The prevalence of PSPA in our sample was 17.8%. Smoking during pregnancy and a pre-pregnancy diagnosis of anxiety were significantly associated with meeting the criteria for PSPA (p = 0.008 and p = 0.013, respectively) and strongly predicted the presence of PSPA (odds ratio 8.54 and 3.44, respectively). CONCLUSIONS FOR PRACTICE: A significant proportion of participants in our sample experienced symptoms consistent with a diagnosis of PSPA. This underscores the importance of further research on PSPA as a unique phenomenon in pregnant women, and the impact it may have on fetal and maternal health outcomes. A greater clinical emphasis should be placed on screening for and treating mental health conditions of pregnancy, including PSPA.
format Online
Article
Text
id pubmed-10067513
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-100675132023-04-03 The Prevalence of Pregnancy-Specific Perinatal Anxiety in Nova Scotia Langille, Courtney Andreou, Pantelis Piccinini-Vallis, Helena Matern Child Health J Brief Report OBJECTIVES: Pregnancy-Specific Perinatal Anxiety (PSPA) is an understudied mental health condition of pregnancy that may affect maternal-fetal health outcomes. The purpose of this study was to determine the prevalence of PSPA among pregnant women in the province of Nova Scotia, Canada, as well as the factors associated with it. METHODS: A sample of 90 pregnant women provided data on PSPA symptomology and demographic co-variables via a self-report online survey. The prevalence of PSPA in the sample was calculated and bivariate statistics and binomial logistic regression were conducted to assess the relationship between the presence of PSPA and the independent variables. RESULTS: The prevalence of PSPA in our sample was 17.8%. Smoking during pregnancy and a pre-pregnancy diagnosis of anxiety were significantly associated with meeting the criteria for PSPA (p = 0.008 and p = 0.013, respectively) and strongly predicted the presence of PSPA (odds ratio 8.54 and 3.44, respectively). CONCLUSIONS FOR PRACTICE: A significant proportion of participants in our sample experienced symptoms consistent with a diagnosis of PSPA. This underscores the importance of further research on PSPA as a unique phenomenon in pregnant women, and the impact it may have on fetal and maternal health outcomes. A greater clinical emphasis should be placed on screening for and treating mental health conditions of pregnancy, including PSPA. Springer US 2023-04-02 2023 /pmc/articles/PMC10067513/ /pubmed/37005936 http://dx.doi.org/10.1007/s10995-023-03639-y Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Brief Report
Langille, Courtney
Andreou, Pantelis
Piccinini-Vallis, Helena
The Prevalence of Pregnancy-Specific Perinatal Anxiety in Nova Scotia
title The Prevalence of Pregnancy-Specific Perinatal Anxiety in Nova Scotia
title_full The Prevalence of Pregnancy-Specific Perinatal Anxiety in Nova Scotia
title_fullStr The Prevalence of Pregnancy-Specific Perinatal Anxiety in Nova Scotia
title_full_unstemmed The Prevalence of Pregnancy-Specific Perinatal Anxiety in Nova Scotia
title_short The Prevalence of Pregnancy-Specific Perinatal Anxiety in Nova Scotia
title_sort prevalence of pregnancy-specific perinatal anxiety in nova scotia
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067513/
https://www.ncbi.nlm.nih.gov/pubmed/37005936
http://dx.doi.org/10.1007/s10995-023-03639-y
work_keys_str_mv AT langillecourtney theprevalenceofpregnancyspecificperinatalanxietyinnovascotia
AT andreoupantelis theprevalenceofpregnancyspecificperinatalanxietyinnovascotia
AT piccininivallishelena theprevalenceofpregnancyspecificperinatalanxietyinnovascotia
AT langillecourtney prevalenceofpregnancyspecificperinatalanxietyinnovascotia
AT andreoupantelis prevalenceofpregnancyspecificperinatalanxietyinnovascotia
AT piccininivallishelena prevalenceofpregnancyspecificperinatalanxietyinnovascotia